TrialNMR in biomedicine2013

Response of HT29 colorectal xenograft model to cediranib assessed with 18 F-fluoromisonidazole positron emission tomography, dynamic contrast-enhanced and diffusion-weighted MRI.

Louisa Bokacheva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.